Breaking News

IQVIA Launches RIM Smart Labeling for Global Label Management

Facilitates proactive monitoring of global label changes through real-time workflow tracking.

IQVIA launched IQVIA RIM Smart Labeling, a comprehensive labeling solution for the life sciences industry that provides an intelligence-driven approach for more efficient and compliant global label management. Through this unique solution, life sciences companies can consolidate regulatory label planning, tracking and execution systems and workflows into one streamlined process.

RIM Smart Labeling is part of IQVIA’s suite of purpose-built regulatory, safety and quality technology solutions and services. Label management is an extremely complex, highly regulated process spanning multiple systems, geographies, and stakeholders. An adjustment at any point in this ecosystem could trigger a labeling change. RIM Smart Labeling simplifies, automates, and streamlines the global management of label changes through:

• Orchestrating workflow from change request through implementation
• Utilizing regulatory intelligence for implementation of global and country-specific labels, information translations and artwork
• Facilitating structured content management to ensure consistency and accuracy of core and regional labels
• Integrating reporting and dashboards to provide end-to-end visibility of the global label management process

RIM Smart Labeling facilitates the proactive monitoring of global label changes through real-time workflow tracking, supporting regulatory compliance and centralizing notifications, alerts, and tasks.

“IQVIA RIM Smart Labeling empowers organizations to streamline and standardize global label management across an increasingly intricate regulatory environment,” said Joe Rymsza, vice president, global safety, regulatory and quality technology solutions at IQVIA. “With this solution, life sciences companies can focus on reducing label management costs and complexity while heightening compliance operations across geographies and stakeholders.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters